Sterol 14α-demethylase mutation leads to amphotericin B resistance in Leishmania mexicana
暂无分享,去创建一个
Terry K. Smith | Isabel M. Vincent | M. Barrett | N. Dickens | P. Herzyk | Dong-Hyun Kim | D. Creek | K. Burgess | G. Lepesheva | M. Mudaliar | R. Burchmore | Julie Kovářová | Stefan Weidt | Andrew W. Pountain | R. Mwenechanya | S. Weidt
[1] R. Tubiana,et al. Antimony to Cure Visceral Leishmaniasis Unresponsive to Liposomal Amphotericin B , 2016, PLoS neglected tropical diseases.
[2] J. McKerrow,et al. Targeting Ergosterol Biosynthesis in Leishmania donovani: Essentiality of Sterol 14alpha-demethylase , 2015, PLoS neglected tropical diseases.
[3] F. Hsu,et al. Sterol Biosynthesis Is Required for Heat Resistance but Not Extracellular Survival in Leishmania , 2014, PLoS pathogens.
[4] S. Murta/,et al. Functional analysis of cytosolic tryparedoxin peroxidase in antimony-resistant and –susceptible Leishmania braziliensis and Leishmania infantum lines , 2014, Parasites & Vectors.
[5] M. Dikhit,et al. Ascorbate Peroxidase, a Key Molecule Regulating Amphotericin B Resistance in Clinical Isolates of Leishmania donovani , 2014, Antimicrobial Agents and Chemotherapy.
[6] S. Sundar,et al. Failure of Miltefosine Treatment for Visceral Leishmaniasis in Children and Men in South-East Asia , 2014, PloS one.
[7] M. Ouellette,et al. Quantitative proteomic analysis of amphotericin B resistance in Leishmania infantum , 2014, International journal for parasitology. Drugs and drug resistance.
[8] Andrew J. Nieuwkoop,et al. Amphotericin forms an extramembranous and fungicidal sterol sponge , 2014, Nature chemical biology.
[9] P. Salotra,et al. Combination therapy with amphotericin-B and miltefosine for post-kala-azar dermal leishmaniasis: a preliminary report. , 2014, Acta dermato-venereologica.
[10] P. Ramani,et al. Detection of species diversity in oral candida colonization and anti-fungal susceptibility among non-oral habit adult diabetic patients , 2014, Journal of natural science, biology, and medicine.
[11] A. Fairlamb,et al. Chronic exposure to arsenic in drinking water can lead to resistance to antimonial drugs in a mouse model of visceral leishmaniasis , 2013, Proceedings of the National Academy of Sciences.
[12] S. Lindquist,et al. Fitness Trade-offs Restrict the Evolution of Resistance to Amphotericin B , 2013, PLoS biology.
[13] Jean-Charles Portais,et al. Cytosolic NADPH Homeostasis in Glucose-starved Procyclic Trypanosoma brucei Relies on Malic Enzyme and the Pentose Phosphate Pathway Fed by Gluconeogenic Flux* , 2013, The Journal of Biological Chemistry.
[14] S. Croft,et al. Recent advances in development of amphotericin B formulations for the treatment of visceral leishmaniasis , 2012, Current opinion in infectious diseases.
[15] S. Castanys,et al. Leishmania donovani Develops Resistance to Drug Combinations , 2012, PLoS neglected tropical diseases.
[16] F. Chappuis,et al. Liposomal amphotericin B as a treatment for human leishmaniasis , 2012, Expert opinion on emerging drugs.
[17] Márcia de Souza Carvalho Melhem,et al. Disseminated Amphotericin-Resistant Fusariosis in Acute Leukemia Patients: Report of Two Cases , 2012, Mycopathologia.
[18] Sébastien Dupont,et al. ERGOSTEROL BIOSYNTHESIS: A FUNGAL PATHWAY FOR LIFE ON LAND? , 2012, Evolution; international journal of organic evolution.
[19] A. Hailu,et al. Sodium Stibogluconate (SSG) & Paromomycin Combination Compared to SSG for Visceral Leishmaniasis in East Africa: A Randomised Controlled Trial , 2012, PLoS neglected tropical diseases.
[20] D. Kelly,et al. Facultative Sterol Uptake in an Ergosterol-Deficient Clinical Isolate of Candida glabrata Harboring a Missense Mutation in ERG11 and Exhibiting Cross-Resistance to Azoles and Amphotericin B , 2012, Antimicrobial Agents and Chemotherapy.
[21] Rainer Breitling,et al. IDEOM: an Excel interface for analysis of LC-MS-based metabolomics data , 2012, Bioinform..
[22] Daniel S. Palacios,et al. Amphotericin primarily kills yeast by simply binding ergosterol , 2012, Proceedings of the National Academy of Sciences.
[23] K. Ferreira-Paim,et al. Antifungal Susceptibility, Enzymatic Activity, PCR-Fingerprinting and ITS Sequencing of Environmental Cryptococcus laurentii Isolates from Uberaba, Minas Gerais, Brazil , 2012, Mycopathologia.
[24] D. Singh,et al. Mechanism of Amphotericin B Resistance in Clinical Isolates of Leishmania donovani , 2011, Antimicrobial Agents and Chemotherapy.
[25] R. Breitling,et al. Toward global metabolomics analysis with hydrophilic interaction liquid chromatography-mass spectrometry: improved metabolite identification by retention time prediction. , 2011, Analytical chemistry.
[26] C. Shaha,et al. CYP5122A1, a Novel Cytochrome P450 Is Essential for Survival of Leishmania donovani , 2011, PloS one.
[27] P. Leprohon,et al. Tolerance to drug-induced cell death favours the acquisition of multidrug resistance in Leishmania , 2011, Cell Death and Disease.
[28] M. Waterman,et al. Substrate Preferences and Catalytic Parameters Determined by Structural Characteristics of Sterol 14α-Demethylase (CYP51) from Leishmania infantum* , 2011, The Journal of Biological Chemistry.
[29] S. Sundar,et al. Unusual Case of Resistance to Amphotericin B in Visceral Leishmaniasis in a Region in India Where Leishmaniasis Is Not Endemic , 2011, Journal of Clinical Microbiology.
[30] R. Breitling,et al. PeakML/mzMatch: a file format, Java library, R library, and tool-chain for mass spectrometry data analysis. , 2011, Analytical chemistry.
[31] S. Sundar,et al. Visceral leishmaniasis: elimination with existing interventions. , 2011, The Lancet. Infectious diseases.
[32] S. Sundar,et al. Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial , 2011, The Lancet.
[33] R. Breitling,et al. Metabolomics to Unveil and Understand Phenotypic Diversity between Pathogen Populations , 2010, PLoS neglected tropical diseases.
[34] D. Kelly,et al. A Clinical Isolate of Candida albicans with Mutations in ERG11 (Encoding Sterol 14α-Demethylase) and ERG5 (Encoding C22 Desaturase) Is Cross Resistant to Azoles and Amphotericin B , 2010, Antimicrobial Agents and Chemotherapy.
[35] Shyam Sundar,et al. Single-dose liposomal amphotericin B for visceral leishmaniasis in India. , 2010, The New England journal of medicine.
[36] Nigel W. Hardy,et al. Proposed minimum reporting standards for chemical analysis , 2007, Metabolomics.
[37] David W. Nes,et al. Cholesterol import fails to prevent catalyst-based inhibition of ergosterol synthesis and cell proliferation of Trypanosoma brucei Published, JLR Papers in Press, November 26, 2006. , 2007, Journal of Lipid Research.
[38] M. Bard,et al. A systematic study of yeast sterol biosynthetic protein-protein interactions using the split-ubiquitin system. , 2005, Biochimica et biophysica acta.
[39] J. Berman,et al. Advances in leishmaniasis , 2005, The Lancet.
[40] M. Chance,et al. Production and Characterization of Stable Amphotericin-Resistant Amastigotes and Promastigotes of Leishmania mexicana , 2005, Antimicrobial Agents and Chemotherapy.
[41] M. Pourshafie,et al. Cloning of S-Adenosyl-l-Methionine:C-24-Δ-Sterol-Methyltransferase (ERG6) from Leishmania donovani and Characterization of mRNAs in Wild-Type and Amphotericin B-Resistant Promastigotes , 2004, Antimicrobial Agents and Chemotherapy.
[42] C. Shaha,et al. Apoptotic Death in Leishmania donovani Promastigotes in Response to Respiratory Chain Inhibition , 2004, Journal of Biological Chemistry.
[43] M. Barrett,et al. Pentose phosphate metabolism in Leishmania mexicana. , 2003, Molecular and biochemical parasitology.
[44] D. Sanglard,et al. Candida albicans Mutations in the Ergosterol Biosynthetic Pathway and Resistance to Several Antifungal Agents , 2003, Antimicrobial Agents and Chemotherapy.
[45] D. Rice,et al. Fatty acid and sterol metabolism: potential antimicrobial targets in apicomplexan and trypanosomatid parasitic protozoa. , 2003, Molecular and biochemical parasitology.
[46] A. Fairlamb,et al. A new expression vector for Crithidia fasciculata and Leishmania. , 2002, Molecular and biochemical parasitology.
[47] S. Sundar. Drug resistance in Indian visceral leishmaniasis , 2001, Tropical medicine & international health : TM & IH.
[48] C. Shaha,et al. Hydrogen peroxide induces apoptosis-like death in Leishmania donovani promastigotes. , 2001, Journal of cell science.
[49] M. Ginger,et al. The Biosynthetic Incorporation of the Intact Leucine Skeleton into Sterol by the Trypanosomatid Leishmania mexicana * , 2001, The Journal of Biological Chemistry.
[50] P. Loiseau,et al. Mechanism of Amphotericin B Resistance inLeishmania donovani Promastigotes , 1998, Antimicrobial Agents and Chemotherapy.
[51] R. Kaminsky,et al. The Alamar Blue assay to determine drug sensitivity of African trypanosomes (T.b. rhodesiense and T.b. gambiense) in vitro. , 1997, Acta tropica.
[52] B. E. Cohen,et al. Amphotericin B Kills Unicellular Leishmanias by Forming Aqueous Pores Permeable to Small Cations and Anions , 1996, The Journal of Membrane Biology.
[53] J. Boothroyd,et al. Molecular cloning and cellular localization of a BiP homologue in Trypanosoma brucei. Divergent ER retention signals in a lower eukaryote. , 1993, Journal of cell science.
[54] H. Gallis,et al. Amphotericin B: 30 years of clinical experience. , 1990, Reviews of infectious diseases.
[55] G. Medoff,et al. Role of cell defense against oxidative damage in the resistance of Candida albicans to the killing effect of amphotericin B , 1988, Antimicrobial Agents and Chemotherapy.
[56] L. W. Parks,et al. Yeast sterols: yeast mutants as tools for the study of sterol metabolism. , 1985, Methods in enzymology.
[57] D. Beach,et al. Sterols of Leishmania species. Implications for biosynthesis. , 1984, Molecular and biochemical parasitology.
[58] R. Brun,et al. A simple monophasic medium for axenic culture of hemoflagellates. , 1976, The Journal of parasitology.
[59] E. Steck. The leishmaniases. , 1974, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.